期刊
LEUKEMIA RESEARCH
卷 30, 期 1, 页码 103-105出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2005.05.008
关键词
ATL; alemtuzumab; pentostatin; HTLV-I
lreatment of adult T-cell leukemia (ATL) remains difficult. Aletntuzumab with or without nucleoside analogs such as pentostatin may provide a role in this setting. However, the associated immunosuppression is a concern in patients with viral-mediated disease. (c) 2005 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据